TY - JOUR
T1 - Cardiomyocyte autophagy
T2 - Remodeling, repairing, and reconstructing the heart
AU - Hill, Joseph A
AU - Cao, Dian J
AU - Gillette, Thomas G.
N1 - Funding Information:
This work was supported by grants from the National Institutes of Health (HL-075173; HL-080144; HL-090842), American Heart Association (0640084N), and the American Heart Association–Jon Holden DeHaan Foundation.
PY - 2009/12
Y1 - 2009/12
N2 - Autophagy is an evolutionarily conserved catabolic pathway of lysosome-dependent turnover of damaged proteins and organelles. When nutrients are in short supply, bulk removal of cytoplasmic components by autophagy replenishes depleted energy stores, a process critical for maintaining cellular homeostasis. However, prolonged activation of autophagic pathways can result in cell death. Longstanding evidence has linked the stimulation of lysosomal pathways to pathologic cardiac remodeling and a number of cardiac diseases, including heart failure and ischemia. Only recently, however, has work begun to parse cytoprotective autophagy from autophagy that contributes to disease pathogenesis. Current thinking suggests that the effects of autophagy exist on a continuum, with the eliciting triggers, the duration and amplitude of autophagic flux, and possibly the targeted intra cellular cargo as critical determinants of the end result. Deciphering how autophagy participates in basal homeostasis of the heart, in aging, and in disease pathogenesis may uncover novel insights with clinical relevance in the treatment of heart disease.
AB - Autophagy is an evolutionarily conserved catabolic pathway of lysosome-dependent turnover of damaged proteins and organelles. When nutrients are in short supply, bulk removal of cytoplasmic components by autophagy replenishes depleted energy stores, a process critical for maintaining cellular homeostasis. However, prolonged activation of autophagic pathways can result in cell death. Longstanding evidence has linked the stimulation of lysosomal pathways to pathologic cardiac remodeling and a number of cardiac diseases, including heart failure and ischemia. Only recently, however, has work begun to parse cytoprotective autophagy from autophagy that contributes to disease pathogenesis. Current thinking suggests that the effects of autophagy exist on a continuum, with the eliciting triggers, the duration and amplitude of autophagic flux, and possibly the targeted intra cellular cargo as critical determinants of the end result. Deciphering how autophagy participates in basal homeostasis of the heart, in aging, and in disease pathogenesis may uncover novel insights with clinical relevance in the treatment of heart disease.
UR - http://www.scopus.com/inward/record.url?scp=72549093841&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=72549093841&partnerID=8YFLogxK
U2 - 10.1007/s11906-009-0070-1
DO - 10.1007/s11906-009-0070-1
M3 - Review article
C2 - 19895751
AN - SCOPUS:72549093841
SN - 1522-6417
VL - 11
SP - 406
EP - 411
JO - Current Hypertension Reports
JF - Current Hypertension Reports
IS - 6
ER -